Iovance Biotherapeutics Ownership | Who Owns Iovance Biotherapeutics?
Iovance Biotherapeutics Ownership Summary
Iovance Biotherapeutics is owned by 17.92% institutional investors, 0.33% insiders, and 81.76% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.70% of IOVA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.79% of its assets in Iovance Biotherapeutics shares.
IOVA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Iovance Biotherapeutics | 17.92% | 0.33% | 81.76% |
| Sector | Healthcare Stocks | 35.74% | 11.83% | 52.43% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 31.08M | 8.70% | $109.09M |
| Mhr fund management | 28.97M | 8.11% | $101.67M |
| Blackrock | 21.23M | 7.97% | $170.23M |
| Vanguard group | 27.21M | 7.47% | $74.28M |
| State street | 17.45M | 4.88% | $61.24M |
| Two sigma investments, lp | 13.69M | 3.83% | $48.04M |
| Millennium management | 9.41M | 2.63% | $33.04M |
| Goldman sachs group | 8.76M | 2.45% | $30.75M |
| Geode capital management | 8.57M | 2.40% | $30.10M |
| Invenomic capital management lp | 8.50M | 2.38% | $29.82M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mhr fund management | 28.97M | 7.43% | $101.67M |
| B group | 1.50M | 3.90% | $5.26M |
| Palo alto investors lp | 6.35M | 3.41% | $22.29M |
| Knott david m jr | 1.60M | 3.34% | $5.62M |
| Orion investment | 2.07M | 2.30% | $7.25M |
| Invenomic capital management lp | 8.50M | 1.37% | $29.82M |
| Cm management | 450.00K | 1.32% | $1.58M |
| Rhenman & partners asset management ab | 2.06M | 0.89% | $7.21M |
| Kennondale capital management | 318.19K | 0.81% | $1.12M |
| Parametrica management | 195.88K | 0.78% | $687.53K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Two sigma investments, lp | 13.69M | 0.04% | 9.29M |
| D. e. shaw | 8.02M | 0.02% | 4.19M |
| Vanguard group | 27.21M | 0.00% | 3.15M |
| Millennium management | 9.41M | 0.01% | 2.83M |
| Marshall wace, llp | 2.36M | 0.01% | 2.36M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Hood river capital management | - | - | -9.22M |
| Long focus capital management | 2.10M | 0.19% | -6.50M |
| Macquarie group | - | - | -4.79M |
| Artisan partners limited partnership | - | - | -4.41M |
| Avoro capital advisors | - | - | -3.50M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Marshall wace, llp | 2.36M | 0.01% | 2.36M | $8.27M |
| Vanguard fiduciary trust | 2.18M | 0.00% | 2.18M | $7.67M |
| Knott david m jr | 1.60M | 3.34% | 1.60M | $5.62M |
| Voloridge investment management | 1.02M | 0.01% | 1.02M | $3.59M |
| Artal group | 1.01M | 0.21% | 1.01M | $8.11M |
Sold Out
| Holder | Change |
|---|---|
| Global financial private client | -4.00 |
| Nbc securities | -4.00 |
| Global retirement partners | -5.00 |
| Pier 88 investment partners | -10.00 |
| Capital performance advisors llp | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 150 | -45.05% | 64,023,711 | -75.53% | 17 | 0.35% | 88 | -41.72% | 29 | -54.69% |
| Dec 31, 2025 | 168 | -35.63% | 143,064,086 | -32.81% | 39 | 0.97% | 89 | -29.37% | 43 | -41.89% |
| Sep 30, 2025 | 247 | 0.82% | 212,726,606 | 4.22% | 63 | 1.71% | 118 | -4.07% | 69 | -1.43% |
| Jun 30, 2025 | 250 | -18.03% | 220,042,797 | -8.11% | 65 | 1.20% | 125 | -19.87% | 74 | -16.85% |
| Mar 31, 2025 | 24 | -92.48% | 69,746,593 | -71.12% | 21 | 0.34% | 12 | -92.36% | 4 | -95.40% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 12.48M | 2.79% | 2.88K |
| Vanguard US Total Market Shares ETF | 8.71M | 2.66% | 762.45K |
| State Street® SPDR® S&P® Biotech ETF | 9.08M | 2.03% | -89.70K |
| iShares Russell 2000 ETF | 7.91M | 1.77% | 66.65K |
| Hood River Small-Cap Growth Instl | 5.10M | 1.53% | - |
| Macquarie Small Cap Core I | 4.08M | 1.22% | 56.67K |
| Invenomic Institutional | 5.02M | 1.22% | 9.67K |
| Vanguard Small Cap Index | 4.51M | 1.01% | -19.32K |
| SPDR® S&P Biotech ETF | 3.56M | 0.98% | 7.96K |
| Delaware Small Cap Core I | 2.61M | 0.86% | 1.84M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 05, 2025 | Kirby Daniel Gordon | Chief Commercial Officer | Buy | $55.20K |
| May 23, 2025 | Puri Raj K. | Chief Regulatory Officer | Buy | $9.74K |
| May 14, 2025 | Vogt Frederick G | Interim CEO & General Counsel | Buy | $42.25K |
| Nov 12, 2024 | Maynard Ryan D | - | Sell | $503.00K |
| Feb 20, 2024 | MCPEAK MERRILL A | - | Buy | $2.29M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 3 | - |
IOVA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools